Last Updated:
COVAXIN Global Push In Top-gear: Bharat Biotech Eyeing US Trials, Interest From 11 Nations
Bharat Biotech is in advanced negotiations with the US FDA for conducting small scale phase-III clinical trials of Covaxin in the US
IMAGE: PTI
Bharat Biotech, the developer of COVAXIN, is in advanced negotiations with the US FDA (Food and Drug Administration) for conducting small-scale phase-III clinical trials of COVAXIN in the US, sources close to the development have said on Monday. The Indian vaccine maker has also held extensive bilateral consultations with Hungary & Brazil too for seeking regulatory approvals for COVAXIN in the respective countries.